Unlike previous works that underline COX-2-independent mechanisms as key drivers of CXB’s pro-oxidant effects, our results show that CXB’s anti-tumor activity is COX-2-dependent and were further confirmed by the addition of exogenous PGE2. This evidence concerns the gene PTGS2 and neoplasm.